BIVDA Report Outlines UK Access Barriers to Genetic, Genomic Diagnostics
Challenges identified in the white paper include a lack of centralized guidance to apply for funding for genomic technologies and a shortage of infrastructure to educate physicians and patients.
UK COVID-19 Test Procurement Process Flawed, BIVDA White Paper Says
A BIVDA official said the report could foster better cooperation between the government and industry moving ahead.
UK IVD Industry Hindered by Lack of Funding, Structural Issues, Report Says
The white paper, called A Strategic Technology Roadmap for the UK In Vitro Diagnostics Industry, was funded by Innovate UK, the UK's national innovation agency.
A shortage of regulatory capacity continues to slow the implementation of the EU's In Vitro Diagnostic Regulation.
The UK government said it will also invest £26 million to support cancer genomics research, and an additional £22 million to improve genomic data diversity.